Hofmann Tobias, Biebl Matthias, Knitter Sebastian, Fehrenbach Uli, Chopra Sascha, Cetinkaya-Hosgor Candan, Raakow Jonas, Seika Philippa, Langer Rupert, Pratschke Johann, Denecke Christian, Kröll Dino
Department of Surgery, Campus Charité Mitte|Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institut of Health, Augustenburger Platz 1, 13353 Berlin, Germany.
Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institut of Health, Augustenburger Platz 1, 13353 Berlin, Germany.
J Clin Med. 2022 Dec 2;11(23):7177. doi: 10.3390/jcm11237177.
(1) Background: Minimally invasive oesophagectomy (MIE) with intrathoracic anastomosis is increasingly used in treating patients with oesophageal cancer. Anastomotic leakage (AL) remains a critical perioperative complication, despite recent advances in surgical techniques. It remains unclear to what extent the size of the circular stapler (CS), a 25 mm CS or a bigger CS, may affect the incidence of AL. This study aimed to evaluate whether the CS size in oesophagogastrostomy affects the postoperative AL rates and related morbidity in MIE. (2) Methods: We conducted a retrospective review of consecutive patients who had undergone thoracic MIE between August 2014 and July 2019 using a CS oesophagogastric anastomosis at the level of the Vena azygos. The patients were grouped according to CS size (mm): small-sized (SS25) and large-sized (LS29). The patient demographics, data regarding morbidity, and clinical outcomes were compared. The primary outcome measure was the AL rate related to the stapler size. (3) Results: A total of 119 patients were included (SS25: = 65; LS29: = 54). Except for the distribution of squamous cell carcinoma, the demographics were similar in each group. The AL rate was 3.7% in the LS29 group and 18.5% in the SS25 group ( = 0.01). The major morbidity (CD ≥ 3a) was significantly more frequent in the SS25 group compared with the LS29 group ( = 0.02). CS size, pulmonary complications, and cardiovascular disease were independent risk factors for AL in the multivariate analysis. (4) Conclusions: A 29 mm CS is associated with significantly improved surgical outcomes following standard MIE at the level of the azygos vein and should be conducted whenever technically feasible.
(1) 背景:采用胸内吻合的微创食管切除术(MIE)在食管癌患者治疗中的应用日益广泛。尽管手术技术最近有所进步,但吻合口漏(AL)仍然是关键的围手术期并发症。目前尚不清楚圆形吻合器(CS)的尺寸,即25mm的CS还是更大尺寸的CS,在多大程度上可能影响AL的发生率。本研究旨在评估食管胃吻合术中CS尺寸是否会影响MIE术后的AL发生率及相关发病率。(2) 方法:我们对2014年8月至2019年7月间在奇静脉水平采用CS进行食管胃吻合的连续胸段MIE患者进行了回顾性研究。患者根据CS尺寸(mm)分组:小尺寸(SS25)和大尺寸(LS29)。比较患者的人口统计学特征、发病率数据和临床结局。主要结局指标是与吻合器尺寸相关的AL发生率。(3) 结果:共纳入119例患者(SS25组:n = 65;LS29组:n = 54)。除鳞状细胞癌分布外,各组的人口统计学特征相似。LS29组的AL发生率为3.7%,SS25组为18.5%(P = 0.01)。与LS29组相比,SS25组的主要并发症(CD≥3a)明显更常见(P = 0.02)。在多变量分析中,CS尺寸、肺部并发症和心血管疾病是AL的独立危险因素。(4) 结论:29mm的CS与奇静脉水平标准MIE术后显著改善的手术结局相关,在技术可行时均应采用。